Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Craniopharyngioma × Surveys and Questionnaires × 1 year × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 43 Neoplasms 25 Prostatic Neoplasms 22 Lung Neoplasms 11 Head and Neck Neoplasms 11 Pancreatic Neoplasms 8 Ovarian Neoplasms 7 Colorectal Neoplasms 7 Oropharyngeal Neoplasms 6 Hematologic Neoplasms 6 Gastrointestinal Neoplasms 6 Urinary Bladder Neoplasms 5 Neoplasm Metastasis 5 Multiple Myeloma 5 Esophageal Neoplasms 5 Depression 5 Brain Neoplasms 5 Sarcoma 4 Motor Activity 4 Lymphoma 4 Endometrial Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Rectal Neoplasms 3 Pain 3 Osteosarcoma 3 Melanoma 3 Genetic Predisposition to Disease 3 Fatigue 3 Communication 3 Chronic Pain 3

Interventions

tocilizumab 2 tozuleristide 1 tovorafenib 1 binimetinib 1 anlotinib 1 Transurethral Resection of Bladder 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Qsymia 1 Proton Therapy 1 Phentermine 1 Methionine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06801756 2025-04-02

CRANIOGESTE

Assistance Publique - Hôpitaux de Paris

Craniopharyngioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡